Kidney Cancer Research Program Service

The government authority located in Washington, DC is seeking a vendor to provide kidney cancer research program services. The agency aims to promote rigorous, innovative, and high-impact research in kidney cancer to benefit service members, veterans, their families, and the American public. This initiative focuses on conquering kidney cancer through collaboration and discovery. The scope of work requires the vendor to encourage innovative ideas with high impact and identify new targets for kidney cancer. The project covers developing pharmacological, immunological, genetic, microbiome, or other interventions, as well as optimizing prognostic or predictive markers to assist with therapeutic decision-making. The agency also requires the vendor to repurpose existing and currently approved interventions, integrate bench research with bedside care, and promote translational research. The selected vendor must invest in early-career kidney cancer physicians to cultivate the next generation of researchers. The work involves facilitating multi-site collaborative clinical research development and clinical trials. Additionally, the vendor must foster collaborations that cross translational, disciplinary, and institutional boundaries. Only onshore organizations based in the United States are eligible to bid on this opportunity. The performance of the requested work will take place offsite. The agency is currently looking for proposals to determine the budget, and specific evaluation criteria and key dates are not provided in the initial solicitation.